186 related articles for article (PubMed ID: 9692546)
1. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.
Cmarik JL; Li Y; Ogram SA; Min H; Reeves R; Colburn NH
Oncogene; 1998 Jul; 16(26):3387-96. PubMed ID: 9692546
[TBL] [Abstract][Full Text] [Related]
2. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.
Ram TG; Reeves R; Hosick HL
Cancer Res; 1993 Jun; 53(11):2655-60. PubMed ID: 8495429
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic properties of the HMG-I gene family.
Wood LJ; Maher JF; Bunton TE; Resar LM
Cancer Res; 2000 Aug; 60(15):4256-61. PubMed ID: 10945639
[TBL] [Abstract][Full Text] [Related]
4. Adhesion, migration, transcriptional, interferon-inducible, and other signaling molecules newly implicated in cancer susceptibility and resistance of JB6 cells by cDNA microarray analyses.
Samuel S; Bernstein LR
Mol Carcinog; 2004 Jan; 39(1):34-60. PubMed ID: 14694446
[TBL] [Abstract][Full Text] [Related]
5. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
Chang PL; Cao M; Hicks P
Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
[TBL] [Abstract][Full Text] [Related]
7. Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro.
Chin MT; Pellacani A; Hsieh CM; Lin SS; Jain MK; Patel A; Huggins GS; Reeves R; Perrella MA; Lee ME
J Mol Cell Cardiol; 1999 Dec; 31(12):2199-205. PubMed ID: 10640447
[TBL] [Abstract][Full Text] [Related]
8. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
Su L; Mukherjee AB; Mukherjee BB
Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
10. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
11. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.
Abe N; Watanabe T; Sugiyama M; Uchimura H; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 1999 Mar; 59(6):1169-74. PubMed ID: 10096541
[TBL] [Abstract][Full Text] [Related]
12. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells.
Colburn NH; Smith BM; Wendel EJ; Dowjat WK; Shimada T
Cancer Res; 1988 Mar; 48(5):1195-200. PubMed ID: 3342399
[TBL] [Abstract][Full Text] [Related]
13. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
14. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
Liu WM; Guerra-Vladusic FK; Kurakata S; Lupu R; Kohwi-Shigematsu T
Cancer Res; 1999 Nov; 59(22):5695-703. PubMed ID: 10582687
[TBL] [Abstract][Full Text] [Related]
15. Genes that cooperate with tumor promoters in transformation.
Colburn NH; Smith BM
J Cell Biochem; 1987 Jun; 34(2):129-42. PubMed ID: 3597557
[TBL] [Abstract][Full Text] [Related]
16. Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines.
Holth LT; Thorlacius AE; Reeves R
DNA Cell Biol; 1997 Nov; 16(11):1299-309. PubMed ID: 9407002
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of TPA and pristane on gene expression and transformation in mouse epidermal cells.
Garrett LR; Ackland-Berglund CE; Jones CJ; Cuchens MA
Exp Cell Res; 1993 Apr; 205(2):416-21. PubMed ID: 8482348
[TBL] [Abstract][Full Text] [Related]
18. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
Chang PL; Chambers AF
J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of 15 and 16 kDa nuclear proteins in promotion sensitive and promotion resistant mouse JB6 cells.
Hirano K; Smith BM; Colburn NH
Oncol Res; 1992; 4(1):17-21. PubMed ID: 1581616
[TBL] [Abstract][Full Text] [Related]
20. 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate- induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1993 May; 53(10 Suppl):2217-20. PubMed ID: 8485706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
